| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.096 | 0.6 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.092 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |